NYSEARCA:KAPA

Kairos Pharma Stock Forecast

etoro logo Buy KAPA
*Your capital is at risk
$0.350
-0.0360 (-9.33%)
At Close: Aug 10, 2026

Should you buy KAPA stock?

Last updated:

Based on market data through , StockInvest.us rates Kairos Pharma, Ltd. (KAPA) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Down 10.26%
  • 3-month trend forecast Down 37.99%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of KAPA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KAPA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very red day for Kairos Pharma, Ltd. stock price after a -9.33% fall in the Monday trading session
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Aug 06, 2026 Loss -10.26%

The Kairos Pharma, Ltd. stock price fell by -9.33% on the last day (Monday, 10th Aug 2026) from $0.386 to $0.350. During the last trading day the stock fluctuated 4.89% from a day low at $0.350 to a day high of $0.367. The price has risen in 6 of the last 10 days and is up by 12.98% over the past 2 weeks. Volume has increased on the last day by 862 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 862 thousand shares were bought and sold for approximately $301.77 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.99% during the next 3 months and, with a 90% probability hold a price between $0.151 and $0.237 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

KAPA Signals & Forecast

The Kairos Pharma, Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.342 and $0.346. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 06, 2026, and so far it has fallen -10.26%. Further fall is indicated until a new bottom pivot has been found. Kairos Pharma, Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Kairos Pharma, Ltd. stock

Kairos Pharma, Ltd. finds support from accumulated volume at $0.340 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0171 between high and low, or 4.89%. For the last week, the stock has had daily average volatility of 10.75%.

Our recommended stop-loss: $0.332 (-5.04%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (KAPA) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Kairos Pharma, Ltd. to open at $0.356, and during the day (based on 14 day Average True Range), to move between $0.331 and $0.369, which gives a possible trading interval of +/-$0.0386 (+/-11.68%) up or down from last closing price. If Kairos Pharma, Ltd. takes out the full calculated possible swing range there will be an estimated 11.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.358 (2.29%) than the support at $0.340 (2.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Kairos Pharma, Ltd. stock A Buy?

Kairos Pharma, Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.356 ( 1.63%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KAPA Performance

Trading levels for KAPA

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.373 6.51%
R2 0.366 4.65%
R1 0.362 3.49%
Price 0.350
S1 0.349 -0.238%
S2 0.345 -1.39%
S3 0.339 -3.26%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.390 11.43%
R2 0.375 7.09%
R1 0.358 2.29%
Price 0.350
S1 0.340 -2.89%
S2 0.318 -9.14%
S3 0.313 -10.66%

FAQ

What is the symbol for Kairos Pharma, Ltd. Stock and on which exchange is it traded?
The symbol for Kairos Pharma, Ltd. is KAPA and it is traded on the NYSEARCA (NYSE Arca).

Should I buy or sell Kairos Pharma, Ltd. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Kairos Pharma, Ltd. (KAPA) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 06, 2026, the price has fallen 10.26%. The current 3-month trend forecast projects a fall of 37.99%.

How to buy Kairos Pharma, Ltd. Stock?
Kairos Pharma, Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kairos Pharma, Ltd. Stock.

What's the current price of Kairos Pharma, Ltd. Stock?
As of the end of day on the Aug 10, 2026, the price of an Kairos Pharma, Ltd. (KAPA) share was $0.350.

What is the 52-week high and low for Kairos Pharma, Ltd. Stock?
The 52-week high for Kairos Pharma, Ltd. Stock is $2.11 and the 52-week low is $0.270.

What is the market capitalization of Kairos Pharma, Ltd. Stock?
As of the Aug 10, 2026, the market capitalization of Kairos Pharma, Ltd. is 7.494M.

When is the next earnings date for Kairos Pharma, Ltd.?
The upcoming earnings date for Kairos Pharma, Ltd. is Aug 11, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE